{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:06:41Z","timestamp":1781086001888,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To estimate whether nitrofurantoin prophylaxis decreases the incidence of culture-documented urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This double-blind, placebo-controlled, randomized trial was conducted at five academic institutions. Women with urinary retention after surgery for prolapse or incontinence were randomized to oral nitrofurantoin 100 mg daily during indwelling or clean intermittent self-catheterization. The primary outcome was the incidence of symptomatic urinary tract infection within 6 weeks of surgery, confirmed by culture demonstrating more than 1,000 colony forming units per milliliter of uropathogenic bacteria. Secondary outcomes were adverse symptoms possibly attributable to nitrofurantoin and bacterial resistance to nitrofurantoin. A sample size of 154 would detect a decrease in urinary tract infection incidence from 33% to 13%, with 80% power, two-sided alpha of 0.05, and allow 10% dropout.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 154 participants randomized from September 2016 to May 2018, 151 were eligible for analysis: 75 received nitrofurantoin, and 76 received placebo. Demographics were similar between groups. The indication for surgery was prolapse (46%), incontinence (20%), or a combination (34%). Participants were discharged with an indwelling catheter (58%) or performing self-catheterization (42%). Median duration of catheter use was 4 days (interquartile range 3\u20137). Thirteen women in the nitrofurantoin group and 13 women in the placebo group experienced urinary tract infection (17.3% vs 17.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>=.97, relative risk [RR] [95% CI] 1.01 [0.50\u20132.04]). Adverse symptoms possibly attributable to nitrofurantoin were common in both groups (68% vs 61%, <jats:italic toggle=\"yes\">P<\/jats:italic>=.34, RR [95% CI] 1.12 [0.88\u20131.43]). Resistance to nitrofurantoin was identified in seven urine cultures, four among nitrofurantoin and three among placebo recipients. In total, 52 urine cultures were obtained to evaluate symptoms of urinary tract infection, and only 27 of 52 grew at least 1,000 cfu\/mL of uropathogenic bacteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Daily nitrofurantoin did not reduce the incidence of culture-proven urinary tract infection among women with catheter-managed urinary retention after pelvic reconstructive surgery. Culture confirmed urinary tract infection in only half of symptomatic episodes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT02727322.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003462","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T11:43:25Z","timestamp":1568115805000},"page":"727-735","source":"Crossref","is-referenced-by-count":19,"title":["Antibiotic Prophylaxis During Catheter-Managed Postoperative Urinary Retention After Pelvic Reconstructive Surgery"],"prefix":"10.1097","volume":"134","author":[{"given":"Erin Seifert","family":"Lavelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakeeza","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Florian-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Elmer-Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charelle","family":"Carter-Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Mazloomdost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Zyczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Lowder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Sutkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa070416","article-title":"Burch colposuspension versus fascial sling to reduce urinary stress incontinence","volume":"356","author":"Albo","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.juro.2009.01.019","article-title":"Complications in women undergoing Burch colposuspension versus autologous rectus fascial sling for stress urinary incontinence","volume":"181","author":"Chai","year":"2009","journal-title":"J Urol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00192-011-1429-9","article-title":"Risk factors for urinary tract infection following incontinence surgery","volume":"22","author":"Nygaard","year":"2011","journal-title":"Int Urogynecol J"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00192-010-1137-x","article-title":"Symptomatic urinary tract infections after surgery for prolapse and\/or incontinence","volume":"21","author":"Sutkin","year":"2010","journal-title":"Int Urogynecol J"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1056\/NEJMoa1111967","article-title":"A midurethral sling to reduce incontinence after vaginal prolapse repair","volume":"366","author":"Wei","year":"2012","journal-title":"N Engl J Med"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00192-008-0696-6","article-title":"Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis","volume":"19","author":"Fitzgerald","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/AOG.0000000000000286","article-title":"Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery","volume":"123","author":"Wu","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/SPV.0b013e3182544e03","article-title":"Treatment for urinary tract infection after midurethral sling: a retrospective study comparing patients who receive short-term postoperative catheterization and patients who pass a void trial on the day of surgery","volume":"18","author":"Dieter","year":"2012","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/AOG.0000000000000024","article-title":"Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial","volume":"123","author":"Dieter","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ajog.2004.03.088","article-title":"A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and\/or stress urinary incontinence with suprapubic catheterization","volume":"191","author":"Rogers","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20230711","first-page":"183","article-title":"Reapppraisal of risk\/benefit of nitrofurantoin: review of toxicity and efficacy","volume":"8","author":"Shah","year":"1989","journal-title":"Adverse Drug React Acute Poisoning Rev"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200161030-00004","article-title":"An update on the role of nitrofurans in the management of urinary tract infections","volume":"61","author":"Guay","year":"2001","journal-title":"Drugs"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cmi.2015.05.022","article-title":"Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin","volume":"21","author":"Giske","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00192-009-0885-y","article-title":"Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis","volume":"20","author":"Sutkin","year":"2009","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/0140-6736(92)91529-H","article-title":"Prophylactic ciprofloxacin for catheter-associated urinary-tract infection","volume":"339","author":"van der Wall","year":"1992","journal-title":"Lancet"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2015.04.003","article-title":"Cranberry juice capsules and urinary tract infection post surgery: results of a randomized trial","volume":"213","author":"Foxman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/SPV.0000000000000486","article-title":"Length of catheter use after hysterectomy as a risk factor for urinary tract Infection","volume":"24","author":"Karp","year":"2018","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM197408012910501","article-title":"Factors predisposing to bacteriuria during indwelling urethral catheterization","volume":"291","author":"Garibaldi","year":"1974","journal-title":"N Engl J Med"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:59:05Z","timestamp":1689105545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003462"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003462","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}